RxDoctor Payments Data

Nicholas Romeo, DO

Orthopaedic Trauma · Cleveland, OHNPI 1033408224

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 67.6% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $8,286, 2.2 times the $3,739 reported in 2019.

$21,862in general payments, 2019–2025

Across 72 payments — averaging $303.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes GmbH$15K
  • Smith+Nephew$5K
  • Stryker$1K
  • Medical Device Business Services, Inc.$194
  • Johnson & Johnson$120
  • Next Science LLC$87
  • plus $12 from 1 others
$18,898in research payments, 2019–2025

Across 6 payments — averaging $3149.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$19K

What the payments were for

  • Speaking & faculty fees$9,00041%
  • Travel & lodging$9,05741%
  • Food & beverage$3,80517%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,862 in reported general payments places this provider in the 60th percentile of 38 orthopaedic trauma providers in Ohio.

See all orthopaedic trauma providers in Ohio

Medicare billing

Part B allowed, 2024
$92,057
Medicare patients
134
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam34$109

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →